Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2019 1
2020 3
2021 5
2022 6
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. Raison CL, et al. Among authors: gukasyan n. JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530. JAMA. 2023. PMID: 37651119 Free PMC article.
Psychedelic-Assisted Therapy for People with Eating Disorders.
Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS. Gukasyan N, et al. Curr Psychiatry Rep. 2022 Dec;24(12):767-775. doi: 10.1007/s11920-022-01394-5. Epub 2022 Nov 14. Curr Psychiatry Rep. 2022. PMID: 36374357 Review.
Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.
Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS. Yaden DB, et al. Among authors: gukasyan n. Int J Neuropsychopharmacol. 2021 Aug 20;24(8):615-623. doi: 10.1093/ijnp/pyab026. Int J Neuropsychopharmacol. 2021. PMID: 33987652 Free PMC article. Review.
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.
Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK. Levin AW, et al. Among authors: gukasyan n. PLoS One. 2024 Mar 14;19(3):e0300501. doi: 10.1371/journal.pone.0300501. eCollection 2024. PLoS One. 2024. PMID: 38483940 Free PMC article. Clinical Trial.
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.
Yaden DB, Gukasyan N, Nayak SM. Yaden DB, et al. Among authors: gukasyan n. JAMA Psychiatry. 2024 Jun 1;81(6):541-542. doi: 10.1001/jamapsychiatry.2023.4680. JAMA Psychiatry. 2024. PMID: 38055240 Clinical Trial. No abstract available.
24 results